Works matching IS 13889842 AND DT 2020 AND VI 22 AND IP 9
Results: 38
Corrigendum to 'Transcatheter tricuspid valve therapies: exploring the dark side of the moon' [Eur J Heart Fail 2018;20:1063-1065].
- Published in:
- 2020
- Publication type:
- Journal Article
Is myosin activation a new treatment for heart failure?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Spironolactone: diuretic or disease‐modifying drug in heart failure with preserved ejection fraction?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1611, doi. 10.1002/ejhf.1979
- By:
- Publication type:
- Article
Searching for diagnostic biomarkers of heart failure with preserved ejection fraction: methodological issues.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1598, doi. 10.1002/ejhf.1977
- By:
- Publication type:
- Article
Targeting longevity genes in the battle against diabetic heart disease – is there a gene delivery fountain of youth?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1582, doi. 10.1002/ejhf.1942
- By:
- Publication type:
- Article
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1649, doi. 10.1002/ejhf.1933
- By:
- Publication type:
- Article
Looking at the heart failure through the prism of liver dysfunction.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1672, doi. 10.1002/ejhf.1932
- By:
- Publication type:
- Article
Using antimatter to uncover what matters: metformin effects on myocardial efficiency in heart failure.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Improving physical activity and exercise capacity in heart failure. Taking the first step is always the hardest.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1734, doi. 10.1002/ejhf.1934
- By:
- Publication type:
- Article
Angiotensin receptor–neprilysin inhibition in heart failure with preserved ejection fraction: lessons from PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1525, doi. 10.1002/ejhf.1976
- By:
- Publication type:
- Article
Secrets of spironolactone: continuing insights from TOPCAT Americas.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1625, doi. 10.1002/ejhf.1959
- By:
- Publication type:
- Article
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC)
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1504, doi. 10.1002/ejhf.1957
- By:
- Publication type:
- Article
Regional adiposity and heart failure with preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1540, doi. 10.1002/ejhf.1956
- By:
- Publication type:
- Article
Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1495, doi. 10.1002/ejhf.1954
- By:
- Publication type:
- Article
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1586, doi. 10.1002/ejhf.1944
- By:
- Publication type:
- Article
All rise! Orthostatic hypotension in heart failure: reply.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1742, doi. 10.1002/ejhf.1927
- By:
- Publication type:
- Article
Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1600, doi. 10.1002/ejhf.1917
- By:
- Publication type:
- Article
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1615, doi. 10.1002/ejhf.1909
- By:
- Publication type:
- Article
All rise! Orthostatic hypotension in heart failure. Letter regarding the article 'Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients'.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1741, doi. 10.1002/ejhf.1904
- By:
- Publication type:
- Article
Characterization of the inflammatory‐metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1551, doi. 10.1002/ejhf.1902
- By:
- Publication type:
- Article
Rationale and study design of OUTSTEP‐HF: a randomised controlled study to assess the effect of sacubitril/valsartan and enalapril on physical activity measured by accelerometry in patients with heart failure with reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1724, doi. 10.1002/ejhf.1919
- By:
- Publication type:
- Article
Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Heart failure with preserved ejection fraction diagnostic scores in an Asian population.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A novel strategy for the management of lung congestion: targeting TRPV4 channel, the 'gate keeper' of pulmonary capillary permeability.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Istaroxime in acute heart failure: the holy grail is at HORIZON?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF-1/CXCR4 signalling pathway.
- Published in:
- 2020
- By:
- Publication type:
- journal article
From PARADIGM to PARAGON further evidence supporting continuous heart failure spectrum.
- Published in:
- 2020
- By:
- Publication type:
- journal article
With great power comes great… reliability.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Targeting pulmonary capillary permeability to reduce lung congestion in heart failure: a randomized, controlled pilot trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Understanding the results of the PARAGON-HF trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. i, doi. 10.1002/ejhf.1962
- Publication type:
- Article
The neglected issue of cardiac amyloidosis in trials on heart failure with preserved ejection fraction in the elderly.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1711, doi. 10.1002/ejhf.1716
- By:
- Publication type:
- Article
A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1628, doi. 10.1002/ejhf.1656
- By:
- Publication type:
- Article
Mega-trials in heart failure: effects of dilution in examination of new therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo‐controlled trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1684, doi. 10.1002/ejhf.1743
- By:
- Publication type:
- Article